Treatment with IDegAsp was superior in lowering fasting PG ( ETD -@ mmol/L -LSB- @ % CI -@ to -@ -RSB- , P < @ ) and had a significantly lower final mean daily insulin dose ( estimated rate ratio @ -LSB- @ % CI @-@ @ -RSB- , P = @ ) .